最后更新: 2026年4月29日

Female urinary retention is a rare condition compared to males — literature shows an incidence ratio of female to male as low as 1:13. The reason is that women do not have a prostate gland, which is the most common cause of bladder outlet obstruction in aging men. However, when acute urinary retention (AUR) does occur in a female, it presents a complex diagnostic and management challenge even for experienced physicians.

Acute urinary retention female
Acute urinary retention in females is a challenging condition requiring specialist evaluation.

The etiology of female urinary retention is almost always multifactorial, requiring careful step-by-step assessment. I categorize the management into two clinical episodes.

Female urinary retention multifactorial causes
Female urinary retention is often caused by multiple overlapping factors requiring individualized treatment.

Two clinical episodes of female urinary retention

  1. Acute episode — First presentation or symptoms present for less than 6 weeks. This is treated as a potentially reversible condition, and the priority is identifying and correcting the underlying cause. Common acute triggers include the postpartum period and urological anti-incontinence surgery.
  2. Chronic episode — Urinary retention that persists even after correctable causes have been addressed. Causes are divided into:
    • Bladder causes — neurogenic bladder, underactive detrusor
    • Bladder outlet obstruction — gynecological tumors, urethral tumors, or pregnancy
Chronic female urinary retention
Chronic female urinary retention is diagnosed when the condition fails to reverse after correcting the underlying cause.

The immediate management for AUR in any patient is bladder decompression. When the bladder is overdistended beyond its functional limit, the surrounding nerve fibers become injured and require a period of rest to recover their contractile function.

Step-by-step management of female AUR

Urethral catheter female urinary retention
Urethral catheterization is used for bladder decompression in female urinary retention.

Published data shows a 92.6% success rate after correction of the underlying etiology of female AUR, so this is a manageable condition with the right specialist approach.

你可以访问我的 官方主页在这里.

Frequently Asked Questions About Acute Urinary Retention in Females

Why is acute urinary retention less common in women than men?

Women do not have a prostate gland, which is the most common cause of bladder outlet obstruction in aging men. The female urethra is also shorter and wider, making mechanical obstruction less likely. Literature shows a female-to-male incidence ratio of approximately 1:13 for acute urinary retention. However, when it does occur in women, the etiology is typically complex and multifactorial, requiring thorough specialist evaluation.

What are the most common causes of acute urinary retention in women?

Common acute triggers include the postpartum period (after childbirth) and complications following urological anti-incontinence surgery. Chronic causes include neurogenic bladder dysfunction, underactive detrusor (bladder muscle weakness), gynecological or urethral tumors causing outlet obstruction, and pregnancy. Since causes are often multifactorial, a systematic diagnostic workup by a urologist is essential to identify all contributing factors before initiating treatment.

What is the treatment for acute urinary retention in women?

The immediate treatment is bladder decompression via urethral catheterization or clean intermittent catheterization, which allows the overdistended bladder to rest and recover. The underlying etiology is identified and corrected simultaneously. After 1–14 days of decompression, a voiding trial is performed. Published data shows a 92.6% success rate after well-corrected etiology. If the voiding trial fails, bladder decompression is continued and the clinical situation is reassessed by a specialist.

If you or a family member is experiencing difficulty urinating or has been diagnosed with female urinary retention, Dr. Soarawee Weerasopone offers specialist consultations at Bangkok Hospital Headquarters. 预约咨询.

**免责声明:** 本内容由曼谷医院总院的认证泌尿科医生 Soarawee Weerasopone 医生撰写和审阅。本内容仅用于教育目的,不构成医疗建议。在开始任何医疗治疗前,请务必咨询合格的医疗专业人士。.

医学撰写与审阅: 素瓦瑞·维拉宋蓬医生(Pom医生)— 曼谷医院总部认证泌尿科医生。 国际学者:贝勒医学院(美国)· 顺天堂大学(日本)· 长庚纪念医院(台湾)。.

发表评论

zh_CN简体中文

了解 Dr. Soarawee Weerasopone — Urologist Bangkok 的更多信息

立即订阅以继续阅读并访问完整档案。

继续阅读